6QC.F TOWA PHARMA. CO.

Healthcare Pharmaceuticals Frankfurt Exchange
18.60 EUR
Close of Nov 11, 2026
15.66 23.10
Market cap
EUR 916M
P/E
19.4x
P/B
0.92x
ROE
12.1%
Dividend yield
2.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 6QC.F undervalued?

Graham number
Price18.60
Graham value20.86
Discount10.8%

6QC.F trades 10.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TOWA PHARMA. CO. fundamental analysis

No fundamental analysis for TOWA PHARMA. CO. yet.

TOWA PHARMA. CO. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TOWA PHARMA. CO.

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT se…

Full company profile